{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-22-000060","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.164131+00:00","generated_at":"2026-06-26T03:37:57.663309+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q1 sales up 9.2% organic to $4.3B; lowers adjusted EPS guidance to lower end of $9.60-$10.00","bullets":["Reported net sales $4.3B (+8.1%), organic +9.2%; MedSurg +10.8%, Orthopaedics and Spine +7.2%.","Adjusted EPS $1.97 (+2.1%); adjusted operating margin 21.8% contracted 170 bps.","Revised 2022 outlook: organic sales growth at high end of 6-8%; adjusted EPS at lower end of $9.60-$10.00.","Expects supply chain shortages and inflation to persist; currency headwind ~1.2% on sales, ~$0.10-$0.15 on adj. EPS."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-22-000060","json":"https://secwatch.observer/filing/0000310764-22-000060.json","markdown":"https://secwatch.observer/filing/0000310764-22-000060.md","text":"https://secwatch.observer/filing/0000310764-22-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000060/0000310764-22-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000060/syk-20220428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:37:57.663309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}